《大行報告》高盛:友邦(01299.HK)首季新業務價值符預期 聚焦內地業務次季復甦
高盛發表報告表示,友邦保險(01299.HK)公布今年首季新業務價值8.41億美元,按實質匯率計跌28%(按固定匯率基準計跌27%),大致符合該行預期(該行原預期跌26%及24%)。高盛指業績並無令人意外的地方,因疫情令各國實施旅遊限制及社交距離措施,已明顯影響到友邦旗下中國內地及香港(2月和3月),以至東盟市場(3月)的新業務價值表現。
該行認為,投資者已預期友邦首季業務受到疫情的影響,並將會聚焦公司今年餘下時間的業務表現,但估計友邦第二季新業務價值可能受中國內地業務去年同期一次性的因素影響,並相信投資者對友邦中國業務銷售復甦的殷切關注,而公司已指友邦中國3月銷售明顯較2月強。
高盛維持對友邦「買入」投資評級及該行「確信買入」名單,維持目標價86元,此相當今明兩年股價對內涵價值的2.1倍及1.9倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.